BASSAGANYA-RIERA JOSEP (Chairman, President and CEO) sold 1.9% of their position (103.53K shares) of LANDOS BIOPHARMA, INC. on the open market
Open‑market sale worth $668.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/8/2021ACC: 0001843575-21-000007
DirectorOfficer10% Owner· Chairman, President and CEO
Since Feb 2021
-103.53K
Net shares
Net seller
$668.2K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
103.53K disposed
Non-Derivative Transactions3
common stock
Indirect
Shares
−36K
Price / share
$6.17
Trade value
$221.98K
% of position
0.7%
12/6/2021
5.43M→5.39M
common stock
Indirect
Shares
−42K
Price / share
$6.58
Trade value
$276.53K
% of position
0.8%
12/7/2021
5.39M→5.35M
common stock
Indirect
Shares
−25.53K
Price / share
$6.65
Trade value
$169.72K
% of position
0.5%
12/8/2021
5.35M→5.32M
Total
Net shares
−103.53K
Net value
-$668.23K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| common stock Indirect | 12/6/2021 | S · Sale | −36K | $6.17 | $221.98K | 0.7% | 5.43M | 5.39M |
| common stock Indirect | 12/7/2021 | S · Sale | −42K | $6.58 | $276.53K | 0.8% | 5.39M | 5.35M |
| common stock Indirect | 12/8/2021 | S · Sale | −25.53K | $6.65 | $169.72K | 0.5% | 5.35M | 5.32M |
| Total | −103.53K | -$668.23K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
common stock
IndirectShares owned786.30K
common stock
IndirectShares owned766.40K
common stock
IndirectShares owned823.96K
Total
2.38M indirect2.38M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| common stock | 786.30K | Indirect |
| common stock | 766.40K | Indirect |
| common stock | 823.96K | Indirect |
| Total | 2.38M | 2.38M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported